Squarepoint’s American Renal Associates Holdings, Inc ARA Stock Holding History

Squarepoint’s Portfolio ARA Stock Details ARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-16,040	Closed	-$111K	–	3432
2020 Q3	$111K	Sell	16,040 -399	-2%	-$2.62K	﹤0.01%	2269
2020 Q2	$107K	Sell	16,439 -23,542	-59%	-$152K	﹤0.01%	2000
2020 Q1	$264K	Sell	39,981 -28,658	-42%	-$250K	0.01%	1356
2019 Q4	$712K	Buy	+68,639	New	+$587K	﹤0.01%	1552
2019 Q3	–	Sell	-33,721	Closed	-$251K	–	2815
2019 Q2	$251K	Buy	+33,721	New	+$222K	﹤0.01%	2005
2019 Q1	–	Sell	-10,863	Closed	-$125K	–	2548
2018 Q4	$125K	Buy	+10,863	New	+$185K	﹤0.01%	1778

Other funds holding ARA

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Squarepoint's ARA Position: Q4 2020 in Review

Squarepoint sold out of American Renal Associates Holdings, Inc (ARA) in Q4 2020, closing a stake of 16,040 shares — an estimated $111K sold.

Squarepoint first reported a position in ARA in Q4 2018 and held it in 6 quarters. The position peaked at $712K in Q4 2019. 67 funds tracked by Wall St. Rank hold ARA as of Q4 2020.

Squarepoint reported no remaining American Renal Associates Holdings, Inc position as of Q4 2020 after selling out during the quarter.
Squarepoint sold 16,040 American Renal Associates Holdings, Inc shares in Q4 2020, an estimated $111K.
Squarepoint first reported a position in American Renal Associates Holdings, Inc in Q4 2018 and held it in 6 quarters.
Squarepoint's American Renal Associates Holdings, Inc position peaked at $712K in Q4 2019.
67 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q4 2020.

Based on Squarepoint's 13F filing for Q4 2020, filed 16 Feb 2021.